S. Oertle, H. Mauron, and P. Villiger, “Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders”, Swiss Med Wkly, vol. 132, no. 2930, pp. 414–414, Jul. 2002.